Oppenheimer & Co’s Niagen Bioscience, Inc. Common Stock NAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,900
| Closed | -$89.7K | – | 1690 |
|
|
2024
Q4 | $89.7K | Hold |
16,900
| – | – | ﹤0.01% | 1509 |
|
|
2024
Q3 | $61.7K | Hold |
16,900
| – | – | ﹤0.01% | 1477 |
|
|
2024
Q2 | $46.1K | Sell |
16,900
-2,700
| -14% | -$7.37K | ﹤0.01% | 1409 |
|
|
2024
Q1 | $68.2K | Sell |
19,600
-8,000
| -29% | -$27.8K | ﹤0.01% | 1403 |
|
|
2023
Q4 | $39.5K | Hold |
27,600
| – | – | ﹤0.01% | 1358 |
|
|
2023
Q3 | $40.3K | Hold |
27,600
| – | – | ﹤0.01% | 1349 |
|
|
2023
Q2 | $43.3K | Hold |
27,600
| – | – | ﹤0.01% | 1388 |
|
|
2023
Q1 | $42.2K | Sell |
27,600
-2,500
| -8% | -$3.83K | ﹤0.01% | 1349 |
|
|
2022
Q4 | $50.6K | Sell |
30,100
-100
| -0.3% | -$168 | ﹤0.01% | 1314 |
|
|
2022
Q3 | $37K | Sell |
30,200
-8,910
| -23% | -$10.9K | ﹤0.01% | 1333 |
|
|
2022
Q2 | $65K | Buy |
39,110
+21,900
| +127% | +$36.4K | ﹤0.01% | 1356 |
|
|
2022
Q1 | $42K | Sell |
17,210
-7,900
| -31% | -$19.3K | ﹤0.01% | 1444 |
|
|
2021
Q4 | $94K | Buy |
25,110
+2,900
| +13% | +$10.9K | ﹤0.01% | 1448 |
|
|
2021
Q3 | $139K | Hold |
22,210
| – | – | ﹤0.01% | 1432 |
|
|
2021
Q2 | $219K | Buy |
22,210
+2,600
| +13% | +$25.6K | ﹤0.01% | 1387 |
|
|
2021
Q1 | $183K | Sell |
19,610
-3,900
| -17% | -$36.4K | ﹤0.01% | 1360 |
|
|
2020
Q4 | $113K | Buy |
+23,510
| New | +$113K | ﹤0.01% | 1305 |
|
|
2019
Q1 | – | Sell |
-50,000
| Closed | -$172K | – | 1397 |
|
|
2018
Q4 | $172K | Sell |
50,000
-42,500
| -46% | -$146K | 0.01% | 1127 |
|
|
2018
Q3 | $397K | Hold |
92,500
| – | – | 0.01% | 951 |
|
|
2018
Q2 | $343K | Hold |
92,500
| – | – | 0.01% | 1006 |
|
|
2018
Q1 | $389K | Buy |
92,500
+50,000
| +118% | +$210K | 0.01% | 948 |
|
|
2017
Q4 | $250K | Buy |
+42,500
| New | +$250K | 0.01% | 1130 |
|